Billets de Michelle Dawson

Billet publié sur Twitter/X le 11/05/2021 03:24

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Chantel Ritter, Katherine Hewitt, Carly A. McMorris (2021). Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review. Journal of Child and Adolescent Psychopharmacology, 31(4), 244-258. SAGE Publications.

Date de publication
01/05/2021
Identifiant
10.1089/cap.2020.0110
Auteurs
Chantel Ritter, Katherine Hewitt, Carly A. McMorris
Source
Journal of Child and Adolescent Psychopharmacology
Détails
31(4), 244-258
Type de référence
article
Éditeur
SAGE Publications
Source de métadonnées
crossref

Résumé

Objectives: Majority of youth with autism are taking two or more medications (psychotropic or nonpsychotropic) simultaneously, also known as polypharmacy. Yet the efficacy and the potential outcomes of polypharmacy in this population are widely unknown. This systematic literature review described the trends of polypharmacy among autistic youth, and identified factors associated with polypharmacy. Methods: Sixteen studies were included, encompassing over 300,000 youth with autism. Results: Rates of polypharmacy varied quite substantially across studies, ranging from 6.8% to 87% of autistic youth. Having psychiatric comorbidities, self-injurious behaviors, and physical aggression, as well as being male and older, were associated with higher rates of polypharmacy. Conclusion: Findings emphasize the importance of further research to determine appropriate practices related to the monitoring of adverse side effects, and the long-term impact of polypharmacy among autistic youth.

Auteur·ices de l’étude dans cette référence citée